Jia Xu

Jia Xu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2022 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
GLGuangyan Liu
Guangyan Liu
YLYunxia Li
Yunxia Li
JZJiaming Zhou
Jiaming Zhou
JXJia Xu
Jia Xu
BYBiao Yang
Biao Yang

15 July 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TXTing Xue
Ting Xue
WDWeiqin Du
Weiqin Du
CLChaofeng Liu
Chaofeng Liu
WDWenjuan Dai
Wenjuan Dai
LWLei Wang
Lei Wang
LCLufeng Chen
Lufeng Chen
Pneumocystis pneumonia (PCP) is a life-threatening opportunistic infection in immunocompromised individuals. Standard treatment with trimethoprim-sulfamethoxazole is limited by frequent side effects, potential drug resistance, and diminishing efficacy in certain patients, highlighting the need for alternative therapeutic strategies. This study evaluates the therapeutic and prophylactic potential of baicalin (Ba), a flavonoid derived from traditional Chinese medicine, in an immunosuppressed rat model of PCP. The therapeutic experiment involved intragastric administration of Ba at doses of 100, 200, or 400 mg/kg/day for 4 weeks in immunosuppressed rats, in comparison with intragastric administration of TMP-SMZ (50-250 mg/kg/day). Ba treatment demonstrated a dose-dependent reduction in Pneumocystis burden, alongside improved general health and lung histopathological scores, as well as elevated CD4 + T-cell counts, comparable to the effects observed with TMP-SMZ. In the prophylactic experiment, Ba (100 mg/kg/day) was administered intragastrically for 7 weeks, followed by 5 weeks of continued immunosuppression without further Ba treatment. Ba-treated rats exhibited significantly higher CD4 + T-cell counts, lower CD8 + T-cell counts, and attenuated inflammatory cytokine profiles. The effects of Ba treatment are associated with anti-inflammatory and antioxidant activities, regulation of protease/anti-protease balance, and inhibition of pulmonary collagen deposition. These findings support Ba's potential as an alternative treatment regimen for PCP.

26 August 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
TXTing Xue
Ting Xue
LFLijuan Fan
Lijuan Fan
WDWeiqin Du
Weiqin Du
XCXingxu Chen
Xingxu Chen
CLChaofeng Liu
Chaofeng Liu
SRShouan Ren
Shouan Ren
Background: Pneumocystis pneumonia (PCP) remains a major cause of morbidity and mortality in immunocompromised individuals. Although baicalin (Ba), a natural bioactive flavonoid, has demonstrated protective and therapeutic effects against PCP, its molecular mechanisms remain undefined. We employed dual RNA sequencing (dual RNA-seq) to characterize host and pathogen transcriptional responses to Ba treatment in an immunosuppressed rat model of PCP. Methods: Comparative transcriptomic analyses identified differentially expressed genes in both the host and Pneumocystis , followed by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and gene set enrichment analyses. Candidate targets were further investigated using network pharmacology, protein–protein interaction analysis, molecular docking, and molecular dynamics simulations. Key findings were validated by immunohistochemistry, enzyme-linked immunosorbent assay, and quantitative PCR. Results: Ba markedly remodeled host and pathogen transcriptomes. Host transcriptomic analyses showed that Ba attenuated inflammatory and oxidative stress responses by modulating immune-related pathways, including Toll-like receptor, NF-κB, cytokine-cytokine receptor interaction, chemokine signaling, Th17 cell differentiation, and antigen processing and presentation. Experimental validation demonstrated that Ba reduced pulmonary expression of indoleamine 2,3-dioxygenase 1 (IDO1), Toll-like receptor 2 (TLR2), and TLR4 while increasing nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream antioxidant enzyme heme oxygenase-1 (HO-1). Pathogen transcriptomic analysis identified Pneumocystis Rtt109 ( PcRtt109 ), a fungal histone acetyltransferase, as a potential pathogen-specific target that was significantly downregulated after Ba treatment. Molecular docking and molecular dynamics simulations supported stable interactions between Ba and IDO1, Nrf2, TLR2, TLR4, and PcRtt109 , with the strongest predicted binding observed for PcRtt109 . Conclusion: Dual RNA-seq revealed that Ba exerts anti-PCP activity through coordinated modulation of host and pathogen molecular networks. Its therapeutic effects are associated with suppression of inflammatory signaling, enhancement of antioxidant defenses, and inhibition of a fungal virulence-associated target. These findings provide mechanistic insights into host-pathogen interactions during PCP and support Ba as a potential therapeutic candidate for PCP.

13 March 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
NCNan Cao
Nan Cao
MLMing-Xin Li
Ming-Xin Li
MZMing-Yan Zhu
Ming-Yan Zhu
YWYu Wang
Yu Wang
BWBing Wan
Bing Wan
JXJia Xu
Jia Xu
Objective: The study aimed to assess the antibiotic resistance characteristics and molecular typing of methicillin-resistant Staphylococcus aureus (MRSA) in patients with postoperative infection, as well as potential MRSA reservoirs within the Hand and Foot Surgery department. Methods: Infectious specimens were collected from patients with postoperative infection in the Department of Hand and Foot Surgery at a hospital in Shenyang, China between June 2021 and June 2022. Nasal swab samples were obtained from healthcare workers, patients’ family members, and cleaning staff, and environmental samples were collected from hospital wards. Bacterial identification was performed using a mass spectrometer, and antibiotic susceptibility testing was conducted using the VITEK2-Compact automated bacterial analyzer. Molecular typing was performed via staphylococcal protein A ( spa ) typing and multilocus sequence typing (MLST). Results: Among 1,161 nasal swab samples, 25 MRSA strains were detected, giving a detection rate of 2.24%. One MRSA isolate was found in 77 environmental samples. Twenty-nine MRSA strains were identified in 406 postoperative infectious specimens, primarily from wound secretions and pus. Nasal swab-derived MRSA exhibited 100% resistance to benzylpenicillin and oxacillin; greater than 80% resistance to erythromycin and clindamycin; and 100% sensitivity to vancomycin, ceftaroline, and tigecycline. MRSA from infectious specimens exhibited a resistance rate of 86.21% to erythromycin and clindamycin. spa typing detected t437, t034, and t078 as the dominant genotypes, as they accounted for 16.36, 12.73, and 14.55% of isolates, respectively. MLST typing identified ST398, ST25, and ST59 as the predominant sequence types, each representing 19.23, 19.23, and 17.31% of isolates, respectively. Conclusion: This study identified the molecular typing, antibiotic resistance characteristics, and clonal overlaps suggesting potential transmission reservoirs of MRSA in the Department of Hand and Foot Surgery, providing important guidance for clinical treatment and hospital infection control.